These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36320259)

  • 1. A novel immunochemotherapy based on immunogenicity-activated and immunosuppression-reversed biomimetic nanoparticles.
    Zuo H; Tao J; Wang M; Xie X; Sun M
    RSC Adv; 2022 Sep; 12(43):28104-28112. PubMed ID: 36320259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
    Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
    J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase A silencing for enhanced cancer immunochemotherapy.
    Xia C; Li M; Ran G; Wang X; Lu Z; Li T; Tang X; Zhang Z; He Q
    J Control Release; 2021 Jul; 335():557-574. PubMed ID: 34051289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic Hybrid Nanovesicles of Liposomes and Tumor-Derived Nanovesicles for Cancer Immunochemotherapy.
    Hu M; Zhang J; Kong L; Yu Y; Hu Q; Yang T; Wang Y; Tu K; Qiao Q; Qin X; Zhang Z
    ACS Nano; 2021 Feb; 15(2):3123-3138. PubMed ID: 33470095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone.
    Zhou S; Shang Q; Wang N; Li Q; Song A; Luan Y
    J Control Release; 2020 Dec; 328():617-630. PubMed ID: 32976902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer.
    Zang X; Song J; Yi X; Piyu J
    J Mater Chem B; 2022 Mar; 10(12):2019-2027. PubMed ID: 35254372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of immunogenic activation and immunosuppressive reversion using mitochondrial-respiration-inhibited platelet-mimicking nanoparticles.
    Mai X; Zhang Y; Fan H; Song W; Chang Y; Chen B; Shi J; Xin X; Teng Z; Sun J; Teng G
    Biomaterials; 2020 Feb; 232():119699. PubMed ID: 31891817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death.
    Choi Y; Yoon HY; Kim J; Yang S; Lee J; Choi JW; Moon Y; Kim J; Lim S; Shim MK; Jeon S; Kwon IC; Kim K
    Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33260446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted elimination of myeloid-derived suppressor cells via regulation of the STAT pathway alleviates tumor immunosuppression in neuroblastoma.
    Xu W; Li S; Li M; Yang X; Xie S; Lin L; Li G; Zhou H
    Immunol Lett; 2021 Dec; 240():31-40. PubMed ID: 34600949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma Immunochemotherapy: Targeted Delivery of Doxorubicin via a Dual Functional Nanocarrier.
    Zhai Q; Chen Y; Xu J; Huang Y; Sun J; Liu Y; Zhang X; Li S; Tang S
    Mol Pharm; 2017 Nov; 14(11):3888-3895. PubMed ID: 28850241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced activity of doxorubicin in drug resistant A549 tumor cells by encapsulation of P-glycoprotein inhibitor in PLGA-based nanovectors.
    Xu L; Li H; Wang Y; Dong F; Wang H; Zhang S
    Oncol Lett; 2014 Feb; 7(2):387-392. PubMed ID: 24396453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.
    Yuan SJ; Xu YH; Wang C; An HC; Xu HZ; Li K; Komatsu N; Zhao L; Chen X
    J Nanobiotechnology; 2019 Oct; 17(1):110. PubMed ID: 31623629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetrable Nanoplatform for "Cold" Tumor Immune Microenvironment Reeducation.
    Chen Q; He Y; Wang Y; Li C; Zhang Y; Guo Q; Zhang Y; Chu Y; Liu P; Chen H; Zhou Z; Zhou W; Zhao Z; Li X; Sun T; Jiang C
    Adv Sci (Weinh); 2020 Sep; 7(17):2000411. PubMed ID: 32995118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming the T cell response to cancer by simultaneous, nanoparticle-mediated PD-L1 inhibition and immunogenic cell death.
    Phung CD; Nguyen HT; Choi JY; Pham TT; Acharya S; Timilshina M; Chang JH; Kim JH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
    J Control Release; 2019 Dec; 315():126-138. PubMed ID: 31672625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.
    Li TF; Li K; Zhang Q; Wang C; Yue Y; Chen Z; Yuan SJ; Liu X; Wen Y; Han M; Komatsu N; Xu YH; Zhao L; Chen X
    Biomaterials; 2018 Oct; 181():35-52. PubMed ID: 30071380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remodeling tumor immunosuppression with molecularly imprinted nanoparticles to enhance immunogenic cell death for cancer immunotherapy.
    He Y; Wu S; Yuan Y; Sun Y; Ai Q; Zhou R; Chai G; Chen D; Hu H
    J Control Release; 2023 Oct; 362():44-57. PubMed ID: 37579978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity.
    Yang S; Shim MK; Kim WJ; Choi J; Nam GH; Kim J; Kim J; Moon Y; Kim HY; Park J; Park Y; Kim IS; Ryu JH; Kim K
    Biomaterials; 2021 May; 272():120791. PubMed ID: 33831739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoengineering a metal-organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells.
    Fan Q; Zuo J; Tian H; Huang C; Nice EC; Shi Z; Kong Q
    J Exp Clin Cancer Res; 2022 May; 41(1):162. PubMed ID: 35501823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
    Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
    J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of novel microwave-sensitized mPEG-PLGA@ZrO
    Mao J; Tang S; Hong D; Zhao F; Niu M; Han X; Qi J; Bao H; Jiang Y; Fu C; Long D; Meng X; Su H
    Nanoscale; 2017 Mar; 9(10):3429-3439. PubMed ID: 28233003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.